The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment

Dhaun N, Melville V, Kramer W, Stavros F, Coyne T, Swan S, et al. Br J Clin Pharmacol. 2007;64(6):733-737.